Bill
SB 1055
SB 1055 requires a formal rate study of reimbursement for substance use disorder services to inform policy, pricing, and funding decisions.
SB 1055 directs the state to conduct a formal rate study related to substance use disorders (SUD). The bill aims to evaluate current rates, costs, and payment structures associated with SUD services and to provide findings that could inform policy decisions, pricing, reimbursement, and program funding. The overall objective is to improve understanding of financial aspects of SUD treatment and support services in order to enhance access, efficiency, and outcomes.
Mandated Rate Study: The bill requires an official rate study focusing on rates paid for substance use disorder services. This includes examining how services are reimbursed, barriers created by current rate structures, and opportunities for adjustments to better align payments with services rendered.
Scope of Services: The study likely covers a range of SUD-related services, which may include inpatient and outpatient treatment, counseling, medication-assisted treatment (MAT), recovery support, and other related behavioral health services. The exact scope will be defined in the accompanying directives or implementation plan.
Data and Methodology: The bill emphasizes the collection and analysis of data on current reimbursement levels, payer mix (e.g., state programs, private insurers, and Medicaid), utilization patterns, and cost drivers. Methodologies may include rateable service categorization, cost analyses, and benchmarking against comparable states or national standards.
Stakeholder Engagement: The study is expected to involve input from stakeholders such as state health agencies, providers, payers, and possibly patient advocates to ensure the findings reflect operational realities and impacts on access and quality of care.
Recommendations and Reporting: Upon completion, the study would yield findings and recommendations. This could include proposed adjustments to rates, policy changes, or pilot programs intended to improve access to SUD treatment and the sustainability of provider networks.
Substance Use Disorder Providers: Hospitals, outpatient clinics, inpatient facilities, MAT providers, and other treatment and recovery services that bill for SUD-related care would be directly analyzed in the rate study; results may influence future reimbursement structures.
Payers: State programs, Medicaid, and private insurers that reimburse SUD services could be impacted by recommended rate changes or policy adjustments.
Individuals Receiving SUD Services: Patients could experience changes in access or affordability if rate adjustments influence provider participation, service availability, or out-of-pocket costs.
State Agencies and Policymakers: Departments of Health and Human Resources or related fiscal and health agencies responsible for implementing the study, reviewing findings, and pursuing any enacted rate changes.
Introduction and Referral: The bill was introduced on February 21, 2026, and initially circulated through Health and Human Resources, then Finance committees.
Action History:
Next Steps (if enacted):
If you’d like, I can tailor this summary to specific audiences (e.g., providers, policymakers, or general public) or pull out any available fiscal implications and potential implementation scenarios once the bill’s full text is released.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
